tiprankstipranks
Advertisement
Advertisement

AUTL Stock Latest News

Autolus Therapeutics: Strategic Positioning and Leadership Drive Confident Buy Rating
RatingsAutolus Therapeutics: Strategic Positioning and Leadership Drive Confident Buy Rating
6d ago
AUTL
Autolus Therapeutics files to sell 54.58M American Depositary Shares for holders
PremiumThe Fly
Autolus Therapeutics files to sell 54.58M American Depositary Shares for holders
7d ago
AUTL
Autolus Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Autolus Therapeutics files $150M mixed securities shelf
7d ago
AUTL
Autolus Highlights ALL Opportunity and AUCATZYL CAR-T Platform
PremiumCompany Announcements
Autolus Highlights ALL Opportunity and AUCATZYL CAR-T Platform
11d ago
8K
AUTL
Autolus Therapeutics Balances Growth Ambition With Rising Losses
PremiumCompany Announcements
Autolus Therapeutics Balances Growth Ambition With Rising Losses
19d ago
AUTL
Autolus Therapeutics price target lowered to $10 from $12 at Mizuho
PremiumThe FlyAutolus Therapeutics price target lowered to $10 from $12 at Mizuho
20d ago
AUTL
Autolus: Transition-Year Execution and Aucatzyl Expansion Underscore Buy-Rated Long-Term Upside
Premium
Ratings
Autolus: Transition-Year Execution and Aucatzyl Expansion Underscore Buy-Rated Long-Term Upside
24d ago
AUTL
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
Premium
The Fly
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
24d ago
U
CG
Autolus Highlights AUCATZYL Launch and Pipeline Advancements
PremiumCompany Announcements
Autolus Highlights AUCATZYL Launch and Pipeline Advancements
24d ago
8K
AUTL
Morning Movers: AstraZeneca jumps following tozorakimab trial results
PremiumThe Fly
Morning Movers: AstraZeneca jumps following tozorakimab trial results
24d ago
AGX
AZN
Autolus Therapeutics reports Q4 EPS (34c), consensus (43c)
PremiumThe Fly
Autolus Therapeutics reports Q4 EPS (34c), consensus (43c)
24d ago
AUTL
Options Volatility and Implied Earnings Moves Today, March 27, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 27, 2026
24d ago
CCL
LGN
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
28d ago
AIR
CCL
AUTL Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AUTL Earnings this Week: How Will it Perform?
1M ago
AUTL
Autolus Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Autolus Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
AUTL
Autolus Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
PremiumThe Fly
Autolus Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
2M ago
AUTL
Autolus Therapeutics reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Autolus Therapeutics reports inducement grants under Nasdaq listing rule
2M ago
AUTL
Autolus Therapeutics Signs Long-Term Lentiviral Supply Agreement
PremiumCompany Announcements
Autolus Therapeutics Signs Long-Term Lentiviral Supply Agreement
3M ago
8K
AUTL
Autolus Therapeutics price target lowered to $8 from $10 at Truist
PremiumThe Fly
Autolus Therapeutics price target lowered to $8 from $10 at Truist
3M ago
AUTL
Autolus: Short-Term Revenue Miss, Long-Term Blockbuster Potential Supports Buy Rating
PremiumRatingsAutolus: Short-Term Revenue Miss, Long-Term Blockbuster Potential Supports Buy Rating
3M ago
AUTL
Maintaining Buy on Autolus: Solid Aucatzyl Growth and Extended Cash Runway Support Attractive Risk‑Reward Despite Lowered Targets
Premium
Ratings
Maintaining Buy on Autolus: Solid Aucatzyl Growth and Extended Cash Runway Support Attractive Risk‑Reward Despite Lowered Targets
3M ago
AUTL
Autolus Therapeutics price target lowered to $10 from $11 at Needham
Premium
The Fly
Autolus Therapeutics price target lowered to $10 from $11 at Needham
3M ago
AUTL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >